FDA Issues Guidance on Payor Communications, Non-Label Information

Drug Industry Daily
A A
Two final FDA guidances published Tuesday clarify which information drugmakers can provide to payors and what non-label information they can communicate.

To View This Article:

Login

Subscribe To Drug Industry Daily